This will help to identify PLEKHA1 or its related pathways as potential therapeutic targets, so as to develop new therapeutic strategies and reduce the health burden of T2DM and its related complications such as ED and MI. Here, PLEKHA1 is linked to type 2 diabetes mellitus.